Disclaimer

Oxford University Press makes no representation, express or implied, that the drug dosages in this book are correct. Readers must therefore always check the product information and clinical procedures with the most up to date published product information and data sheets provided by the manufacturers and the most recent codes of conduct and safety regulations. The authors and the publishers do not accept responsibility or legal liability for any errors in the text or for the misuse or misapplication of material in this work. Except where otherwise stated, drug dosages and recommendations are for the non-pregnant adult who is not breastfeeding.

Show Summary Details
Page of

Multimodality Monitoring in Severe Traumatic Brain Injury 

Multimodality Monitoring in Severe Traumatic Brain Injury
Chapter:
Multimodality Monitoring in Severe Traumatic Brain Injury
Author(s):

Abdelhakim Khellaf

, Peter J. A. Hutchinson

, and Adel Helmy

DOI:
10.1093/med/9780190936259.003.0022
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2022. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 02 July 2022

The central aspects of severe traumatic brain injury (sTBI) management are control of intracranial pressure (ICP) and maintenance of adequate delivery of glucose and oxygen to the brain. Brain multimodality monitoring (MMM) is an important tool defined by the concurrent use of multiple brain monitors, typically ICP monitoring, cerebral perfusion pressure (CPP) monitoring (via ICP and invasive arterial monitoring), brain tissue oxygen tension (PbtO2) monitoring, and cerebral microdialysis for brain biochemistry. The aim of brain MMM in patients with sTBI is to help optimize conditions for brain recovery within the neurocritical care unit, prevent secondary injury, and provide individualized therapeutic targets. In this chapter, the authors further elaborate on these concepts and current guidelines with application to a case example.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.